The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

NovoCure (NASDAQ: NVCR) published its first set of quarterly results for 2025, and they pleased more than a few investors.

The biotech Gilead Sciences has been the best-performing healthcare stock in the S&P 500 by far over the past 12 months. Its ...

DP_Colorado 0, Kansas City 1. LOB_Colorado 2, Kansas City 11. 2B_Garcia (6), Perez 2 (6), Witt (10), Renfroe (2). HR_Beck (1), Goodman (4). SB_Garcia (3). Márquez pitched to 2 batters in the 5th.

The suspension of this program follows the firing and departure of up to 20,000 HHS employees, including key personnel such ...

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its high-content imaging technology and AI-powered analysis used to speed drug discovery ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

San Diego biotech Halozyme is suing Merck over an injectable version of its blockbuster cancer drug, alleging that the new formulation will infringe on Halozyme's under-the-skin delivery patents.

The funding will be used to build one of India's largest facilities capable of processing 150 tons of feedstock daily and also expand the scientific team and enter global markets ...